Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 72.50
-0.35 (-0.48%)
Nov 10, 2026, 4:08 PM HKT
Keymed Biosciences Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Keymed Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $105.77. The average 1-year stock price forecast is 45.89% higher than the current stock price, while the lowest is $90.92 (+25.41%) and the highest is $123.06 (+69.74%).
Price Target: $105.77 (+45.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Keymed Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 10 | 10 | 11 | 11 |
| Buy | 4 | 5 | 5 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 13 | 15 | 15 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $98.00 → $110.00 | Buy | Maintains | $98.00 → $110.00 | +51.72% | Oct 23, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +48.97% | Oct 19, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $104.00 | Buy | Maintains | $104.00 | +43.45% | Oct 16, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $90.37 | Buy | Maintains | $90.37 | +24.65% | Aug 26, 2026 |
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $108.30 | Buy | Maintains | $108.30 | +49.38% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
1.63B
from 716.31M
Increased by 127.55%
Revenue Next Year
2.25B
from 1.63B
Increased by 38.09%
EPS This Year
2.98
from -1.81
EPS Next Year
0.29
from 2.98
Decreased by -90.31%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.